Hunan Fangsheng Pharmaceutical Co Ltd (603998):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hunan Fangsheng Pharmaceutical Co Ltd (603998) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9376
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise’ products include tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, sprays, lotions, extracted TCM lotions, small volume injections and bulk pharmaceutical chemicals. It also provides cephalosporins, metacycline hydrochloride capsules, cefminox sodium injections, cefprozil tablets, dispersible tablets, heat clearing and detoxifying tablets. Fangsheng Pharma offers vitamin B granules, chewable tablets, anti-infectives and calcium tablets, among others. The enterprise provides services such as manufacturing, research and development, research and development framework and planning, science and technology. Fangsheng Pharma is headquartered in Changsha, China.

Hunan Fangsheng Pharmaceutical Co Ltd (603998) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hunan Fangsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Hunan Fangsheng Pharma Forms Joint Venture with Gene Technology Company 11
Equity Offering 12
Hunan Fangsheng Pharma Withdraws Plan to Raise Funds in Private Placement of shares 12
Acquisition 13
Hunan Fangsheng Pharma to Invest USD3 Million in Lipomedics 13
Hunan Fangsheng Pharma Plans to Sell its 57.5% Stake in Pharma Subsidiary for USD1.6 Million 14
Hunan Fangsheng Pharmaceutical Co Ltd – Key Competitors 15
Hunan Fangsheng Pharmaceutical Co Ltd – Key Employees 16
Hunan Fangsheng Pharmaceutical Co Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hunan Fangsheng Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Hunan Fangsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hunan Fangsheng Pharma Forms Joint Venture with Gene Technology Company 11
Hunan Fangsheng Pharma Withdraws Plan to Raise Funds in Private Placement of shares 12
Hunan Fangsheng Pharma to Invest USD3 Million in Lipomedics 13
Hunan Fangsheng Pharma Plans to Sell its 57.5% Stake in Pharma Subsidiary for USD1.6 Million 14
Hunan Fangsheng Pharmaceutical Co Ltd, Key Competitors 15
Hunan Fangsheng Pharmaceutical Co Ltd, Key Employees 16

List of Figures
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hunan Fangsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hunan Fangsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Hunan Fangsheng Pharmaceutical Co Ltd (603998):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GCL-Poly Energy Holdings Ltd:発電所・企業SWOT分析
    GCL-Poly Energy Holdings Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Hitachi Zosen Corporation:戦略・SWOT・企業財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lycatel Services Limited:企業の戦略的SWOT分析
    Lycatel Services Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Intuitive Surgical Inc (ISRG):医療機器:M&Aディール及び事業提携情報
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The d …
  • Tullow Oil plc:戦略・SWOT・企業財務分析
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Severn Trent Plc:企業の戦略・SWOT・財務情報
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • West African Development Bank:電力:M&Aディール及び事業提携情報
    Summary West African Development Bank (BOAD) is a public financial institution focused on the balanced development of its member countries of the West African Monetary Union (WAMU). The institution offers financial advisory services; guarantees of bond loans; financial assistance in project preparat …
  • SM Energy Company:企業の戦略・SWOT・財務情報
    SM Energy Company - Strategy, SWOT and Corporate Finance Report Summary SM Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mott MacDonald Group Ltd:企業の戦略的SWOT分析
    Mott MacDonald Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Richardson Electronics Ltd (RELL):企業の財務・戦略的SWOT分析
    Summary Richardson Electronics Ltd (Richardson Electronics) is a technology company that carries out manufacturing of electron tube. The company offers engineered solutions, power grid and microwave tubes and consumables, displays, flat panel detector solutions and parts for diagnostic imaging equip …
  • Oge Energy Corp
    Oge Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Oge Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Arcus SA (ARC):企業の財務・戦略的SWOT分析
    Summary Arcus SA (Arcus) is an information technology service provider that offers integrated systems for document management and mass correspondence management. Its product includes tims controlling system, which is used for telematics operation. It provides document management products such as pri …
  • Dubai Electricity and Water Authority-エネルギー分野:企業M&A・提携分析
    Summary Dubai Electricity and Water Authority (DEWA) generates, transmits and distributes electricity; and conducts desalination of water. DEWA’s power plants included Jebel Ali Power Station D, E, G, K, L Phase I, L Phase II, and M; Aweer Power Station H Phase I, Phase II, and Phase III. The desali …
  • U.S. Geothermal Inc. (HTM)-エネルギー分野:企業M&A・提携分析
    Summary U.S. Geothermal Inc. (USG) is a renewable energy company. It develops and produces electricity from geothermal source. The company owns and operates geothermal power projects in Oregon, Nevada, and Idaho. USG also has interests in geothermal plants under development or exploration stages in …
  • Northrop Grumman Technical Services Inc.:企業の戦略・SWOT・財務分析
    Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report Summary Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Energy Resources of Australia Ltd (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • SensoDetect AB:医療機器:M&Aディール及び事業提携情報
    Summary SensoDetect AB (SensoDetect) is a medical device company that provides diagnostic products. The company develops neuro physiological decision support systems for diagnostics in psychiatric health care and forensics. Its SensoDetect BERA is a test instrument based on brainstem audiometry whic …
  • AGCO Corporation:企業の戦略・SWOT・財務分析
    AGCO Corporation - Strategy, SWOT and Corporate Finance Report Summary AGCO Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Benchmark Electronics Inc (BHE):企業の財務・戦略的SWOT分析
    Benchmark Electronics Inc (BHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆